Atlas Trials

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Clinical trial NCT00334074 · COMPLETED

Trial details

NCT number
NCT00334074
Sponsor
Baylor Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
Start date
2005-08-01
Primary completion
2007-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.